Seres Therapeutics, Inc.
NASDAQ:MCRB · NASDAQ Global Select
+$0.11 today
Vol 0.12M · Avg 0.06M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-10.92%
Period High
$28.63
Period Low
$5.62
Latest
$6.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Opus Genetics, Inc.
NASDAQ:IRD
$339.35M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$150.61M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$139.02M
Spero Therapeutics, Inc.
NASDAQ:SPRO
$127.96M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$104.12M
Seer, Inc.
NASDAQ:SEER
$94.84M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.95M
Actuate Therapeutics Inc
NASDAQ:ACTU
$50.01M
VistaGen Therapeutics, Inc.
VTGN
$22.62M
Applied Therapeutics, Inc.
APLT
$14.86M
What is the latest MCRB filing?
The latest filing shown is 8-K dated Jun 5, 2026.
How many recent filings does MCRB have?
Intrinsic Alpha currently shows 20 recent filings for MCRB.
Explore More
Continue the stock analysis
Jump to another research area for this company.